CD40LG and amyotrophic lateral sclerosis: Tegoprubart is an anti CD154 antibody designed to inhibit innate and adaptive immune responses, and animal model data supports that blocking CD154 with tegoprubart can alter both the inflammatory component of ALS and its progression.